Multidisciplinary Management of Locally Advanced Rectal Cancer: Neoadjuvant Approaches

被引:7
作者
Murugappan, Swaminathan [1 ,2 ,3 ]
Harris, William P. [1 ,2 ,3 ]
Willett, Christopher G. [4 ]
Lin, Edward [1 ,2 ,3 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Seattle Canc Care Alliance, Seattle, WA 98109 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Duke Univ, Med Ctr, Div Radiat Oncol, Durham, NC 27710 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2013年 / 11卷 / 05期
关键词
TOTAL MESORECTAL EXCISION; PHASE-III TRIAL; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; ADJUVANT THERAPY; PROGNOSTIC-SIGNIFICANCE; EUROPEAN ORGANIZATION; CLINICAL-SIGNIFICANCE; COLORECTAL-CANCER; RADIATION-THERAPY;
D O I
10.6004/jnccn.2013.0071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although tumor biology and genomics of colon and rectal cancer are no different, patients with locally advanced rectal cancer (LARC) require neoadjuvant fluoropyrimidine-based chemoradiation and total mesorectal excision. In addition to known clinical risk factors, improved algorithms integrating molecular tools are needed to stratify patients with LARC to improve treatment outcomes and reduce acute and long-term toxicities. Simply combining newer systemic or targeted agents with standard treatment in all patients yielded little success but added toxicities. This article reviews the historical data, current standards of care, and ongoing research efforts regarding biomarkers, molecular imaging, and personalized genomic information.
引用
收藏
页码:548 / 557
页数:10
相关论文
共 86 条
[51]   Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer [J].
Nedrebo, B. S. ;
Soreide, K. ;
Eriksen, M. T. ;
Dorum, L. M. ;
Kvaloy, J. T. ;
Soreide, J. A. ;
Korner, H. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (05) :716-723
[52]   Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer [J].
Nilbert, M ;
Planck, M ;
Fernebro, E ;
Borg, Å ;
Johnson, A .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :942-945
[53]   A human colon cancer cell capable of initiating tumour growth in immunodeficient mice [J].
O'Brien, Catherine A. ;
Pollett, Aaron ;
Gallinger, Steven ;
Dick, John E. .
NATURE, 2007, 445 (7123) :106-110
[54]  
Oates GD, 1996, LANCET, V348, P1605
[55]   IMPROVING ADJUVANT THERAPY FOR RECTAL-CANCER BY COMBINING PROTRACTED-INFUSION FLUOROURACIL WITH RADIATION-THERAPY AFTER CURATIVE SURGERY [J].
OCONNELL, M ;
MARTENSON, JA ;
WIEAND, HS ;
KROOK, JE ;
MACDONALD, JS ;
HALLER, DG ;
MAYER, RJ ;
GUNDERSON, LL ;
RICH, TA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :502-507
[56]  
Pahlman L, 1997, NEW ENGL J MED, V336, P980
[57]   Randomized Phase 3 Trial Comparing Preoperative and Postoperative Chemoradiotherapy With Capecitabine for Locally Advanced Rectal Cancer [J].
Park, Jin-hong ;
Yoon, Sang Min ;
Yu, Chang Sik ;
Kim, Jong Hoon ;
Kim, Tae Won ;
Kim, Jin Cheon .
CANCER, 2011, 117 (16) :3703-3712
[58]   Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial [J].
Quirke, Phil ;
Steele, Robert ;
Monson, John ;
Grieve, Robert ;
Khanna, Subhash ;
Couture, Jean ;
O'Callaghan, Chris ;
Myint, Arthur Sun ;
Bessell, Eric ;
Thompson, Lindsay C. ;
Parmar, Mahesh ;
Stephens, Richard J. ;
Sebag-Montefiore, David .
LANCET, 2009, 373 (9666) :821-828
[59]   Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer - A two stage phase II clinical trial [J].
Resch, Gudrun ;
De Vries, Alexander ;
Oefner, Dietrnar ;
Eisterer, Wolfgang ;
Rabl, Hans ;
Jagoditsch, Michael ;
Gnant, Michael ;
Thaler, Josef .
RADIOTHERAPY AND ONCOLOGY, 2012, 102 (01) :10-13
[60]   Identification and expansion of human colon-cancer-initiating cells [J].
Ricci-Vitiani, Lucia ;
Lombardi, Dario G. ;
Pilozzi, Emanuela ;
Biffoni, Mauro ;
Todaro, Matilde ;
Peschle, Cesare ;
De Maria, Ruggero .
NATURE, 2007, 445 (7123) :111-115